System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Carl Philpott

Otolaryngology — James Paget University Hospitals NHS Foundation Trust, United Kingdom

LeadR Profile

Carl Philpott James Paget University Hospitals NHS Foundation Trust United Kingdom
787 ScienceLeadR Reputation 787

Unlock

Register Login
Network Map

Otolaryngology

Subspecialties: Immunology - Neurology - Pulmonology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Organizations

Source: Pubmed

James Paget University Hospital

Publications Synthesis

Source: Pubmed

Number : 255

Citations

Citations: 13 434 1st author: 61 Last author: 70 Unique author: 9

Main journals

Clin Otolaryngol 36
Rhinology 36
J Laryngol Otol 18
Cochrane Database Syst Rev 14
Authorea (Authorea) 13

Best Journals

Lancet 2

Breakdown by type

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
The APOLLO Trial: A Proof-of-Concept Study for Vitamin A Nasal Drops in COVID-19 Related Post-Infectious Olfactory Dysfunction.
vitamins, proof of concept study, covid-19, therapeutics, vitamin a, sensory receptor cells		Chem Senses20260
Digital intervention for smell training: a real-world study on engagement, adherence, and behavioural dynamics.
smell, nose, digital health		Rhinology20260
Chronic rhinosinusitis: a qualitative study of patient and clinician experiences of the MACRO randomised controlled trial of surgical versus medical management.
ear, recycling, signs and symptoms, rhinosinusitis		BMJ Open20260
Investigating the Effect of Tumour Necrosis Factor Antagonist on Olfaction.
smell, necrosis, therapeutics		Clin Otolaryngol20260
A Cross-Sectional Study Exploring Patient Experiences, Unmet Needs and Desired Support in Those With Olfactory Dysfunction.
cross-sectional studies, anosmia		Clin Otolaryngol20260

Clinical Studies 4

Source: ClinicalTrials

Synthesis

Principal Investigator: 1

By phase:

N/A 2
Phase 3 2

By status:

Completed 3
Recruiting 1

By type:

Interventional 3
Observational 1

By Monocentric/Multicentric:

monocentric 0
multicentric2to4 1
multicentric5to9 0
multicentricup10 3

Main Topics

Otorhinolaryngologic Diseases 1
Respiratory Tract Diseases 1

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST NP)
NCT06338995 — safety, adrenal cortex hormones, polyps, therapeutics, nasal polyps, rhinosinusitis		Phase 3Recruiting2024

LeadR Networks

Main global connection map

Source: Pubmed Source: ClinicalTrials